81314 Pdgfra gene
Also known as: PDGFRA mutation test, GIST genetic marker
Platelet-Derived Growth Factor Receptor Alpha (PDGFRA) gene mutation analysis to identify variants in gastrointestinal stromal tumors.
In Plain Language
Stomach tumor genetic test; Gastrointestinal stromal tumor analysis
Clinical Context
Detects PDGFRA mutations in GIST to predict imatinib response and guide targeted therapy selection, especially in KIT-negative cases.
RVU Information
CPT 81314 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81314?
CPT 81314 (Pdgfra gene) is a Pathology & Lab code. Platelet-Derived Growth Factor Receptor Alpha (PDGFRA) gene mutation analysis to identify variants in gastrointestinal stromal tumors.
Who uses CPT code 81314?
CPT 81314 is used by Pathology, Oncology, Gastroenterology. Detects PDGFRA mutations in GIST to predict imatinib response and guide targeted therapy selection, especially in KIT-negative cases.
When is CPT 81314 used?
Detects PDGFRA mutations in GIST to predict imatinib response and guide targeted therapy selection, especially in KIT-negative cases.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.